Post-earnings recap
Reported
Tue, Nov 9, 2021
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Haemonetics Corp's earnings report indicates significant challenges, particularly reflected in the EPS miss. The stock's sharp decline of 15.37% suggests investor disappointment and concern over the company's current performance and outlook. Without guidance, uncertainty remains about future growth and profitability.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.29 | N/A | -53.60% |
Management expressed concerns about current market conditions impacting performance. They emphasized a focus on long-term strategies despite short-term setbacks.
Management acknowledged the challenges faced during the quarter.
They highlighted ongoing efforts to improve operational efficiency.